A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
What is migraine?
Migraine is a brain condition, not a blood vessel problem or a stress reaction. An attack usually brings throbbing pain on one side of the head, along with nausea and sensitivity to light and sound, and it can last from a few hours to three days. About 1 in 4 people with migraine get an aura first, visual disturbances like flashing lights or zigzag lines that come before the pain. Doctors sort migraine by frequency: episodic means fewer than 15 headache days a month, chronic means 15 or more, with at least 8 of them migraine days, for more than three months.
For most of medical history, migraine was treated with medicines borrowed from other conditions: blood pressure pills, antidepressants, epilepsy drugs. That changed in 2018, when the first medicine designed specifically for migraine was approved. It blocks a molecule called CGRP, which the brain releases during an attack. There are now four CGRP antibodies given by injection and several CGRP blocking pills, called gepants, and they treat both attacks and prevention. In a 2025 real world study of more than 2,000 patients, about 47 percent of people on a CGRP antibody had a meaningful response at three months, compared with about 35 percent on traditional preventives.
Types of migraine clinical trials
Prevention trials. The largest group. These test whether a medicine reduces the number of migraine days per month, usually over 12 weeks or longer. Some compare two approved preventives head to head to learn which works best for whom.
Acute treatment trials. These test medicines taken during an attack and measure whether pain is gone at two hours and whether it stays gone.
Real world and safety studies. After a drug is approved, these follow people using it in everyday life, for example women using a specific medicine around their period, or people with heart risk factors.
Studies of specific groups. Menstrual migraine, chronic migraine that has resisted other treatments, and childhood migraine each have dedicated studies, because they behave differently and were long understudied.
Non drug and mechanism studies. Some trials test things like cocoa extract or probiotics, others use brain scans to understand why migraine becomes chronic. No treatment is promised in mechanism studies, but they shape what gets tested next.
Who can participate in migraine clinical trials?
Migraine studies almost always start with your attack frequency: how many migraine days and headache days you have per month, usually confirmed with a headache diary during a screening period. Second, whether your migraine is episodic or chronic, since most trials enroll one or the other. Third, your treatment history: many prevention trials want people who have tried and stopped two or more preventives, others want people who have never tried one. Some studies focus on specific groups like menstrual migraine or people with medication overuse. Eligibility always varies by study.
Episodic and chronic migraine, and why the line matters for trials
Migraine has no stages, but the episodic versus chronic split matters enormously. Chronic migraine means 15 or more headache days a month, at least 8 of them with migraine features, for over three months. It affects roughly 1 to 2 percent of people, tends to come with more depression, anxiety, and disability, and often develops when episodic migraine slowly escalates, a process called chronification that researchers are actively studying. For trials, the label decides your eligibility: nearly every study says episodic or chronic in its title. Knowing your monthly count tells you at a glance which studies fit.
Do migraine trial participants get paid?
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.
What is the difference between a migraine and a headache?
A headache is a symptom. Migraine is a disease with a recognizable pattern: one sided throbbing pain, nausea, light and sound sensitivity, and sometimes an aura before the pain. Migraine attacks also tend to be disabling, forcing people to stop what they are doing.
How to Enroll in a Clinical Trial for Migraine
Enrolling in a migraine clinical trial through our platform is a straightforward and user-friendly undertaking. The process involves five key steps:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to your requirements.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar.
- Explore Study Details: For in-depth information about each study, simply click the "Learn More" button.
- Complete the Health Profile: After clicking on the "Get started" button you will be taken to our efficient 5-step application process.
Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you.